LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 8 of total 8

Search options

  1. Article ; Online: TAZ facilitates breast tumor growth by promoting an immune-suppressive tumor microenvironment.

    Gershoni, Anat / Hassin, Ori / Nataraj, Nishanth Belugali / Baruch, Sivan / Avioz-Seligman, Adi / Pirona, Anna Chiara / Fellus-Alyagor, Liat / Meir Salame, Tomer / Mukherjee, Saptaparna / Mallel, Giuseppe / Yarden, Yosef / Aylon, Yael / Oren, Moshe

    Molecular oncology

    2023  Volume 17, Issue 12, Page(s) 2675–2693

    Abstract: The core Hippo pathway module consists of a tumour-suppressive kinase cascade that inhibits the transcriptional coactivators Yes-associated protein (YAP) and WW domain-containing transcription regulator protein 1 (WWTR1; also known as TAZ). When the ... ...

    Abstract The core Hippo pathway module consists of a tumour-suppressive kinase cascade that inhibits the transcriptional coactivators Yes-associated protein (YAP) and WW domain-containing transcription regulator protein 1 (WWTR1; also known as TAZ). When the Hippo pathway is downregulated, as often occurs in breast cancer, YAP/TAZ activity is induced. To elaborate the roles of TAZ in triple-negative breast cancer (TNBC), we depleted Taz in murine TNBC 4T1 cells, using either CRISPR/Cas9 or small hairpin RNA (shRNA). TAZ-depleted cells and their controls, harbouring wild-type levels of TAZ, were orthotopically injected into the mammary fat pads of syngeneic BALB/c female mice, and mice were monitored for tumour growth. TAZ depletion resulted in smaller tumours compared to the tumours generated by control cells, in line with the notion that TAZ functions as an oncogene in breast cancer. Tumours, as well as their corresponding in vitro cultured cells, were then subjected to gene expression profiling by RNA sequencing (RNA-seq). Interestingly, pathway analysis of the RNA-seq data indicated a TAZ-dependent enrichment of 'Inflammatory Response', a pathway correlated with TAZ expression levels also in human breast cancer tumours. Specifically, the RNA-seq analysis predicted a significant depletion of regulatory T cells (Tregs) in TAZ-deficient tumours, which was experimentally validated by the staining of tumour sections and by quantitative cytometry by time of flight (CyTOF). Strikingly, the differences in tumour size were completely abolished in immune-deficient mice, demonstrating that the immune-modulatory capacity of TAZ is critical for its oncogenic activity in this setting. Cytokine array analysis of conditioned medium from cultured cells revealed that TAZ increased the abundance of a small group of cytokines, including plasminogen activator inhibitor 1 (Serpin E1; also known as PAI-1), CCN family member 4 (CCN4; also known as WISP-1) and interleukin-23 (IL-23), suggesting a potential mechanistic explanation for its in vivo immunomodulatory effect. Together, our results imply that TAZ functions in a non-cell-autonomous manner to modify the tumour immune microenvironment and dampen the anti-tumour immune response, thereby facilitating tumour growth.
    MeSH term(s) Animals ; Female ; Humans ; Mice ; Hippo Signaling Pathway ; Intracellular Signaling Peptides and Proteins/genetics ; Intracellular Signaling Peptides and Proteins/metabolism ; Transcription Factors/metabolism ; Triple Negative Breast Neoplasms/genetics ; Triple Negative Breast Neoplasms/pathology ; Tumor Microenvironment ; Transcriptional Coactivator with PDZ-Binding Motif Proteins/metabolism
    Chemical Substances Intracellular Signaling Peptides and Proteins ; Transcription Factors ; WWTR1 protein, human ; Transcriptional Coactivator with PDZ-Binding Motif Proteins
    Language English
    Publishing date 2023-10-16
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2415106-3
    ISSN 1878-0261 ; 1574-7891
    ISSN (online) 1878-0261
    ISSN 1574-7891
    DOI 10.1002/1878-0261.13525
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Spatial behavior reflects the mental disorder in OCD patients with and without comorbid schizophrenia.

    Gershoni, Anat / Hermesh, Haggai / Fineberg, Naomi A / Eilam, David

    CNS spectrums

    2014  Volume 19, Issue 1, Page(s) 90–103

    Abstract: Objective: Resolving the entangled nosological dilemma of whether obsessive-compulsive disorder (OCD) with and without schizophrenia (schizo-OCD and OCD, respectively) are two independent entities or whether schizo-OCD is a combined product of its ... ...

    Abstract Objective: Resolving the entangled nosological dilemma of whether obsessive-compulsive disorder (OCD) with and without schizophrenia (schizo-OCD and OCD, respectively) are two independent entities or whether schizo-OCD is a combined product of its parent disorders.
    Methods: Studying motor activity in OCD and in schizo-OCD patients. Performance of the patients was compared with the performance of the same motor task by a matching control individual.
    Results: Behavior in both schizo-OCD and OCD patients differed from controls in the excessive repetition and addition of acts, thus validating an identical OC facet. However, there was a significant difference in spatial behavior. Schizo-OCD patients traveled over a greater area with less focused activity as typical to schizophrenia patients and in contrast to OCD patients, who were more focused and traveled less in a confined area. While schizo-OCD and OCD patients share most of the OC ritualistic attributes, they differ in the greater spread of activity in schizo-OCD, which is related to schizophrenia disorder.
    Discussion: It is suggested that the finding on difference in spatial behavior is a reflection of the mental differences between OCD and schizophrenia. In other words, this could be an overt and observable manifestation of the mental state, and therefore may facilitate the nosology of OC spectrum disorders and OCD.
    Conclusion: It seems as if both the OCD patients' focus on specific thoughts, and the contrasting wandering thoughts of schizophrenia patients, are reflected in the focused activity of the former and wandering from one place to the next of the latter.
    MeSH term(s) Adult ; Aged ; Analysis of Variance ; Data Interpretation, Statistical ; Diagnostic and Statistical Manual of Mental Disorders ; Female ; Humans ; Male ; Middle Aged ; Motor Activity ; Movement ; Obsessive-Compulsive Disorder/complications ; Obsessive-Compulsive Disorder/psychology ; Schizophrenia/complications ; Schizophrenic Psychology ; Space Perception/physiology ; Young Adult
    Language English
    Publishing date 2014-02
    Publishing country United States
    Document type Clinical Trial ; Journal Article
    ZDB-ID 2008418-3
    ISSN 2165-6509 ; 1092-8529
    ISSN (online) 2165-6509
    ISSN 1092-8529
    DOI 10.1017/S1092852913000424
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients.

    Hassin, Ori / Nataraj, Nishanth Belugali / Shreberk-Shaked, Michal / Aylon, Yael / Yaeger, Rona / Fontemaggi, Giulia / Mukherjee, Saptaparna / Maddalena, Martino / Avioz, Adi / Iancu, Ortal / Mallel, Giuseppe / Gershoni, Anat / Grosheva, Inna / Feldmesser, Ester / Ben-Dor, Shifra / Golani, Ofra / Hendel, Ayal / Blandino, Giovanni / Kelsen, David /
    Yarden, Yosef / Oren, Moshe

    Nature communications

    2022  Volume 13, Issue 1, Page(s) 2800

    Abstract: The TP53 gene is mutated in approximately 60% of all colorectal cancer (CRC) cases. Over 20% of all TP53-mutated CRC tumors carry missense mutations at position R175 or R273. Here we report that CRC tumors harboring R273 mutations are more prone to ... ...

    Abstract The TP53 gene is mutated in approximately 60% of all colorectal cancer (CRC) cases. Over 20% of all TP53-mutated CRC tumors carry missense mutations at position R175 or R273. Here we report that CRC tumors harboring R273 mutations are more prone to progress to metastatic disease, with decreased survival, than those with R175 mutations. We identify a distinct transcriptional signature orchestrated by p53R273H, implicating activation of oncogenic signaling pathways and predicting worse outcome. These features are shared also with the hotspot mutants p53R248Q and p53R248W. p53R273H selectively promotes rapid CRC cell spreading, migration, invasion and metastasis. The transcriptional output of p53R273H is associated with preferential binding to regulatory elements of R273 signature genes. Thus, different TP53 missense mutations contribute differently to cancer progression. Elucidation of the differential impact of distinct TP53 mutations on disease features may make TP53 mutational information more actionable, holding potential for better precision-based medicine.
    MeSH term(s) Colorectal Neoplasms/genetics ; Genes, p53 ; Humans ; Mutation ; Phenotype ; Tumor Suppressor Protein p53/genetics ; Tumor Suppressor Protein p53/metabolism
    Chemical Substances Tumor Suppressor Protein p53
    Language English
    Publishing date 2022-05-19
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-022-30481-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins.

    Mukherjee, Saptaparna / Maddalena, Martino / Lü, YiQing / Martinez, Sebastien / Nataraj, Nishanth Belugali / Noronha, Ashish / Sinha, Sansrity / Teng, Katie / Cohen-Kaplan, Victoria / Ziv, Tamar / Arandkar, Sharathchandra / Hassin, Ori / Chatterjee, Rishita / Pirona, Anna-Chiara / Shreberk-Shaked, Michal / Gershoni, Anat / Aylon, Yael / Elazar, Zvulun / Yarden, Yosef /
    Schramek, Daniel / Oren, Moshe

    Proceedings of the National Academy of Sciences of the United States of America

    2022  Volume 119, Issue 17, Page(s) e2119644119

    Abstract: Missense mutations in the p53 tumor suppressor abound in human cancer. Common (“hotspot”) mutations endow mutant p53 (mutp53) proteins with oncogenic gain of function (GOF), including enhanced cell migration and invasiveness, favoring cancer progression. ...

    Abstract Missense mutations in the p53 tumor suppressor abound in human cancer. Common (“hotspot”) mutations endow mutant p53 (mutp53) proteins with oncogenic gain of function (GOF), including enhanced cell migration and invasiveness, favoring cancer progression. GOF is usually attributed to transcriptional effects of mutp53. To elucidate transcription-independent effects of mutp53, we characterized the protein interactome of the p53R273H mutant in cells derived from pancreatic ductal adenocarcinoma (PDAC), where p53R273H is the most frequent p53 mutant. We now report that p53R273H, but not the p53R175H hotspot mutant, interacts with SQSTM1/p62 and promotes cancer cell migration and invasion in a p62-dependent manner. Mechanistically, the p53R273H-p62 axis drives the proteasomal degradation of several cell junction–associated proteins, including the gap junction protein Connexin 43, facilitating scattered cell migration. Concordantly, down-regulation of Connexin 43 augments PDAC cell migration, while its forced overexpression blunts the promigratory effect of the p53R273H-p62 axis. These findings define a mechanism of mutp53 GOF.
    MeSH term(s) Cell Adhesion/genetics ; Cell Line, Tumor ; Cell Movement/genetics ; Genes, p53 ; Humans ; Mutation ; Pancreatic Neoplasms/genetics ; Sequestosome-1 Protein/genetics ; Sequestosome-1 Protein/metabolism ; Tumor Suppressor Protein p53/genetics ; Tumor Suppressor Protein p53/metabolism
    Chemical Substances SQSTM1 protein, human ; Sequestosome-1 Protein ; Tumor Suppressor Protein p53
    Language English
    Publishing date 2022-04-19
    Publishing country United States
    Document type Journal Article
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.2119644119
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state.

    Furth, Noa / Pateras, Ioannis S / Rotkopf, Ron / Vlachou, Vassiliki / Rivkin, Irina / Schmitt, Ina / Bakaev, Deborah / Gershoni, Anat / Ainbinder, Elena / Leshkowitz, Dena / Johnson, Randy L / Gorgoulis, Vassilis G / Oren, Moshe / Aylon, Yael

    Life science alliance

    2018  Volume 1, Issue 5, Page(s) e201800171

    Abstract: Deregulated activity of LArge Tumor Suppressor (LATS) tumor suppressors has broad implications on cellular and tissue homeostasis. We examined the consequences of down-regulation of either LATS1 or LATS2 in breast cancer. Consistent with their proposed ... ...

    Abstract Deregulated activity of LArge Tumor Suppressor (LATS) tumor suppressors has broad implications on cellular and tissue homeostasis. We examined the consequences of down-regulation of either LATS1 or LATS2 in breast cancer. Consistent with their proposed tumor suppressive roles, expression of both paralogs was significantly down-regulated in human breast cancer, and loss of either paralog accelerated mammary tumorigenesis in mice. However, each paralog had a distinct impact on breast cancer. Thus, LATS2 depletion in luminal B tumors resulted in metabolic rewiring, with increased glycolysis and reduced peroxisome proliferator-activated receptor γ (PPARγ) signaling. Furthermore, pharmacological activation of PPARγ elicited LATS2-dependent death in luminal B-derived cells. In contrast, LATS1 depletion augmented cancer cell plasticity, skewing luminal B tumors towards increased expression of basal-like features, in association with increased resistance to hormone therapy. Hence, these two closely related paralogs play distinct roles in protection against breast cancer; tumors with reduced expression of either LATS1 or LATS2 may rewire signaling networks differently and thus respond differently to anticancer treatments.
    Language English
    Publishing date 2018-10-30
    Publishing country United States
    Document type Journal Article
    ISSN 2575-1077
    ISSN (online) 2575-1077
    DOI 10.26508/lsa.201800171
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation.

    Kotler, Eran / Shani, Odem / Goldfeld, Guy / Lotan-Pompan, Maya / Tarcic, Ohad / Gershoni, Anat / Hopf, Thomas A / Marks, Debora S / Oren, Moshe / Segal, Eran

    Molecular cell

    2018  Volume 71, Issue 1, Page(s) 178–190.e8

    Abstract: The TP53 gene is frequently mutated in human cancer. Research has focused predominantly on six major "hotspot" codons, which account for only ∼30% of cancer-associated p53 mutations. To comprehensively characterize the consequences of the p53 mutation ... ...

    Abstract The TP53 gene is frequently mutated in human cancer. Research has focused predominantly on six major "hotspot" codons, which account for only ∼30% of cancer-associated p53 mutations. To comprehensively characterize the consequences of the p53 mutation spectrum, we created a synthetically designed library and measured the functional impact of ∼10,000 DNA-binding domain (DBD) p53 variants in human cells in culture and in vivo. Our results highlight the differential outcome of distinct p53 mutations in human patients and elucidate the selective pressure driving p53 conservation throughout evolution. Furthermore, while loss of anti-proliferative functionality largely correlates with the occurrence of cancer-associated p53 mutations, we observe that selective gain-of-function may further favor particular mutants in vivo. Finally, when combined with additional acquired p53 mutations, seemingly neutral TP53 SNPs may modulate phenotypic outcome and, presumably, tumor progression.
    MeSH term(s) Animals ; Evolution, Molecular ; Gene Library ; HEK293 Cells ; Humans ; Mice ; Mice, Nude ; Mutation ; Neoplasms/genetics ; Neoplasms/metabolism ; Polymorphism, Single Nucleotide ; Protein Domains ; Tumor Suppressor Protein p53/genetics ; Tumor Suppressor Protein p53/metabolism
    Chemical Substances TP53 protein, human ; Trp53 protein, mouse ; Tumor Suppressor Protein p53
    Language English
    Publishing date 2018-07-06
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1415236-8
    ISSN 1097-4164 ; 1097-2765
    ISSN (online) 1097-4164
    ISSN 1097-2765
    DOI 10.1016/j.molcel.2018.06.012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation.

    Kotler, Eran / Shani, Odem / Goldfeld, Guy / Lotan-Pompan, Maya / Tarcic, Ohad / Gershoni, Anat / Hopf, Thomas A / Marks, Debora S / Oren, Moshe / Segal, Eran

    Molecular cell

    2018  Volume 71, Issue 5, Page(s) 873

    Language English
    Publishing date 2018-09-06
    Publishing country United States
    Document type Journal Article ; Published Erratum
    ZDB-ID 1415236-8
    ISSN 1097-4164 ; 1097-2765
    ISSN (online) 1097-4164
    ISSN 1097-2765
    DOI 10.1016/j.molcel.2018.08.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation.

    Aylon, Yael / Gershoni, Anat / Rotkopf, Ron / Biton, Inbal E / Porat, Ziv / Koh, Anna P / Sun, Xiaochen / Lee, Youngmin / Fiel, Maria-Isabel / Hoshida, Yujin / Friedman, Scott L / Johnson, Randy L / Oren, Moshe

    Genes & development

    2016  Volume 30, Issue 7, Page(s) 786–797

    Abstract: The Hippo signaling pathway is a major regulator of organ size. In the liver, Hippo pathway deregulation promotes hyperplasia and hepatocellular carcinoma primarily through hyperactivation of its downstream effector, YAP. The LATS2 tumor suppressor is a ... ...

    Abstract The Hippo signaling pathway is a major regulator of organ size. In the liver, Hippo pathway deregulation promotes hyperplasia and hepatocellular carcinoma primarily through hyperactivation of its downstream effector, YAP. The LATS2 tumor suppressor is a core member of the Hippo pathway. A screen for LATS2-interacting proteins in liver-derived cells identified the transcription factor SREBP2, master regulator of cholesterol homeostasis. LATS2 down-regulation caused SREBP activation and accumulation of excessive cholesterol. Likewise, mice harboring liver-specific Lats2 conditional knockout (Lats2-CKO) displayed constitutive SREBP activation and overexpressed SREBP target genes and developed spontaneous fatty liver disease. Interestingly, the impact of LATS2 depletion on SREBP-mediated transcription was clearly distinct from that of YAP overexpression. When challenged with excess dietary cholesterol, Lats2-CKO mice manifested more severe liver damage than wild-type mice. Surprisingly, apoptosis, inflammation, and fibrosis were actually attenuated relative to wild-type mice, in association with impaired p53 activation. Subsequently, Lats2-CKO mice failed to recover effectively from cholesterol-induced damage upon return to a normal diet. Additionally, decreased LATS2 mRNA in association with increased SREBP target gene expression was observed in a subset of human nonalcoholic fatty liver disease cases. Together, these findings further highlight the tight links between tumor suppressors and metabolic homeostasis.
    MeSH term(s) Animals ; Cholesterol, Dietary/pharmacology ; Fatty Liver/enzymology ; Fatty Liver/genetics ; Gene Deletion ; Gene Expression Regulation/genetics ; Hep G2 Cells ; Homeostasis/genetics ; Humans ; Liver/drug effects ; Liver/enzymology ; Mice, Knockout ; Protein Binding ; Protein-Serine-Threonine Kinases/genetics ; Protein-Serine-Threonine Kinases/metabolism ; Signal Transduction ; Sterol Regulatory Element Binding Protein 2/genetics ; Sterol Regulatory Element Binding Protein 2/metabolism ; Tumor Suppressor Protein p53/genetics ; Tumor Suppressor Protein p53/metabolism ; Tumor Suppressor Proteins/genetics ; Tumor Suppressor Proteins/metabolism
    Chemical Substances Cholesterol, Dietary ; Sterol Regulatory Element Binding Protein 2 ; Tumor Suppressor Protein p53 ; Tumor Suppressor Proteins ; LATS2 protein, human (EC 2.7.1.11) ; LATS2 protein, mouse (EC 2.7.11.1) ; Protein-Serine-Threonine Kinases (EC 2.7.11.1)
    Language English
    Publishing date 2016-03-24
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 806684-x
    ISSN 1549-5477 ; 0890-9369
    ISSN (online) 1549-5477
    ISSN 0890-9369
    DOI 10.1101/gad.274167.115
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top